Lynx1 Capital Management LP Bionomics Limited Transaction History
Lynx1 Capital Management LP
- $279 Million
- Q3 2024
A detailed history of Lynx1 Capital Management LP transactions in Bionomics Limited stock. As of the latest transaction made, Lynx1 Capital Management LP holds 549,673 shares of BNOX stock, worth $142,914. This represents 0.09% of its overall portfolio holdings.
Number of Shares
549,673Holding current value
$142,914% of portfolio
0.09%Shares
5 transactions
Others Institutions Holding BNOX
# of Institutions
10Shares Held
2.5MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.59MShares$414,1800.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$82,1600.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA34.1KShares$8,8750.0% of portfolio
-
Rhumbline Advisers Boston, MA8.3KShares$2,1580.0% of portfolio
-
Morgan Stanley New York, NY894Shares$2320.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $1.95M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...